Qube Research & Technologies Ltd
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 1729829
LONDON, X0
Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,477,217
+$966,443 QoQ
Shares Held
116,961
+261.1% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,034,188,909 across 187 Biotechnology names. ENTA ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in ENTA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,477,217 | 116,961 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $510,774 | 32,389 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $142,682 | 11,920 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $634,374 | 83,912 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $485,025 | 87,867 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $929,654 | 161,679 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,253,756 | 121,019 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $775,397 | 59,784 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,791,832 | 102,625 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,776,871 | 188,828 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,269,716 | 113,672 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $975,754 | 45,596 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $633,047 | 15,654 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,088,381 | 23,396 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,799,837 | 34,699 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $249,821 | 5,285 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $662,187 | 9,303 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $634,059 | 8,479 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||